CHELSEY LOSSEN: Open Payments
NPI 1184275398 · MIDDLEBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,360 in 75 payments from 20 companies in 2025. Trend: 2023 $1,280 · 2024 $1,147 · 2025 $1,360
Food & beverage: $1,360
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 15 | $214 |
| ABBVIE INC. | 9 | $207 |
| PFIZER INC. | 10 | $182 |
| Novo Nordisk Inc | 12 | $172 |
| Lilly USA, LLC | 8 | $145 |
| Exact Sciences Corporation | 4 | $98 |
| Astellas Pharma US Inc | 2 | $61 |
| Lundbeck LLC | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
Products named: TRELEGY ELLIPTA, QULIPTA, Wegovy, ELIQUIS, The Cologuard Plus Collection Kit, MOUNJARO, Veozah, Ozempic.
Industry payments across FL — which companies pay providers there.
